A forward genetics platform for papillomavirus research

The inability to perform forward genetics has been a major barrier to human papillomavirus (HPV) research. Here, we report a platform for phenotypic selection of HPV mutants. Our method relies on large “concordant” virus libraries, where each mutant virus particle encapsidates the mutant plasmid that encodes it, thereby directly linking viral genotype to phenotype. This platform can achieve a ∼2500-fold enrichment of an L1 capsid protein mutant from an excess of wild-type virus. To demonstrate that this system could select rare mutants from complex libraries, we selected and validated antibody escape mutants and showed that two neutralizing antibodies that recognize overlapping epitopes in L1 display distinct patterns of HPV recognition. This genetics approach unlocks previously inaccessible avenues of investigation into the HPV life cycle and provides a powerful engine to develop improved vaccines and novel antiviral strategies.

Authors

Institutions

Publication Details

Journal
Science Advances
Published
2026-09-30
DOI
https://doi.org/10.1126/sciadv.aei3417
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

A forward genetics platform for papillomavirus research

Daniel DiMaio, Yuka Takeo, S Hirsch
Science Advances
Cervical Cancer and HPV Research
article

A forward genetics platform for papillomavirus research

Daniel DiMaio, Yuka Takeo, S Hirsch
article en

Abstract

The inability to perform forward genetics has been a major barrier to human papillomavirus (HPV) research. Here, we report a platform for phenotypic selection of HPV mutants. Our method relies on large “concordant” virus libraries, where each mutant virus particle encapsidates the mutant plasmid that encodes it, thereby directly linking viral genotype to phenotype. This platform can achieve a ∼2500-fold enrichment of an L1 capsid protein mutant from an excess of wild-type virus. To demonstrate that this system could select rare mutants from complex libraries, we selected and validated antibody escape mutants and showed that two neutralizing antibodies that recognize overlapping epitopes in L1 display distinct patterns of HPV recognition. This genetics approach unlocks previously inaccessible avenues of investigation into the HPV life cycle and provides a powerful engine to develop improved vaccines and novel antiviral strategies.

Science AdvancesVol. 12(40)
Yale University (US)
Responsible consumption and production
Openalex Percentile: Top 26%
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.